Abstrakti

Drug combination therapy is a promising strategy to treat complex diseases such as cancer and infectious diseases. However, current knowledge of drug combination therapies, especially in cancer patients, is limited because of adverse drug effects, toxicity and cell line heterogeneity. Screening new drug combinations requires substantial efforts since considering all possible combinations between drugs is infeasible and expensive. Therefore, building computational approaches, particularly machine learning methods, could provide an effective strategy to overcome drug resistance and improve therapeutic efficacy. In this review, we group the state-of-the-art machine learning approaches to analyze personalized drug combination therapies into three categories and discuss each method in each category. We also present a short description of relevant databases used as a benchmark in drug combination therapies and provide a list of well-known, publicly available interactive data analysis portals. We highlight the importance of data integration on the identification of drug combinations. Finally, we address the advantages of combining multiple data sources on drug combination analysis by showing an experimental comparison.
AlkuperäiskieliEnglanti
Artikkeli293
Sivut1-16
Sivumäärä16
JulkaisuBRIEFINGS IN BIOINFORMATICS
Vuosikerta22
Numero6
DOI - pysyväislinkit
TilaJulkaistu - marraskuuta 2021
OKM-julkaisutyyppiA2 Arvio tiedejulkaisuussa (artikkeli)

Sormenjälki

Sukella tutkimusaiheisiin 'Machine learning approaches for drug combination therapies'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Siteeraa tätä